Acceptability and Willingness of UAE Residents to Use OTC Vending Machines to Deliver Self-Testing Kits for COVID-19 and the Implications.
SARS-CoV-2
UAE
attitudes
public acceptability and willingness
self-testing kits
Journal
Journal of multidisciplinary healthcare
ISSN: 1178-2390
Titre abrégé: J Multidiscip Healthc
Pays: New Zealand
ID NLM: 101512691
Informations de publication
Date de publication:
2022
2022
Historique:
received:
12
04
2022
accepted:
04
07
2022
entrez:
30
8
2022
pubmed:
31
8
2022
medline:
31
8
2022
Statut:
epublish
Résumé
Self-testing kits for SARS-CoV-2 appear effective, practical, safe and reliable as well as helping patients with mild-to-moderate symptoms to be successfully managed at home without going to hospital. As a result, ease pressures on hospitals. OTC vending machines offer the potential for SARS-CoV-2 self-testing kits alongside making available OTC treatments to alleviate the symptoms of COVID-19. As a result, providing confidentiality alongside ease of use in case people do not want their status broad casted. Consequently, there was a need to assess the acceptability and willingness regarding the availability of OTC vending machines to dispense self-testing kits for SARS-CoV-2 among UAE residents to provide future direction. A cross-sectional survey using a designed questionnaire was based on previous research and expert input and pilot tested. All items in the final questionnaire were seen as acceptable with a satisfactory content validity. A purposive sampling strategy was used in the principal study by primarily sending a link to the questionnaire to UAE universities via Facebook and WhatsApp. A total of 876 respondents participated in the study and completed the whole questionnaire. Most participants were female (63%), Arabic origin (42%) and holding a bachelor's degree (84.5%). There was high acceptability and willingness to use self-testing kits (87.2%), with 88.6% of respondents believing OTC vending machines would be beneficial for patients with actual or suspected SARS-CoV-2. Gender, nationality, educational level, employment status, having relatives infected with SARS-CoV-2 and being vaccinated were significantly associated with attitudes towards the self-testing kits. Recognised barriers include their potential costs, ease of access and help for those who cannot read the instructions. Overall, there was high acceptability and willingness to use OTC vending machines to deliver self-testing kits for SARS-CoV-2 among the surveyed participants. Key barriers will need to be addressed to enhance their use.
Identifiants
pubmed: 36039076
doi: 10.2147/JMDH.S370441
pii: 370441
pmc: PMC9419902
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1759-1770Informations de copyright
© 2022 Jairoun et al.
Déclaration de conflit d'intérêts
All authors declare that they have no conflict of interest.
Références
N Engl J Med. 2021 Feb 11;384(6):497-511
pubmed: 33264556
Cochrane Database Syst Rev. 2021 Mar 24;3:CD013705
pubmed: 33760236
BMJ. 2020 Oct 19;371:m4057
pubmed: 33077424
Postgrad Med J. 2021 Feb;97(1144):130-132
pubmed: 32561598
Infect Drug Resist. 2020 Dec 29;13:4673-4695
pubmed: 33402839
Front Public Health. 2021 Sep 17;9:741525
pubmed: 34604164
J Community Health. 2021 Dec;46(6):1244-1251
pubmed: 33877534
Expert Rev Respir Med. 2021 Aug;15(8):993-1002
pubmed: 33896332
BMC Public Health. 2021 May 29;21(1):1015
pubmed: 34051769
Lancet. 2020 May 30;395(10238):1678-1680
pubmed: 32401713
JMIR Res Protoc. 2021 Nov 26;10(11):e33088
pubmed: 34726608
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Front Pharmacol. 2021 Jan 14;11:582154
pubmed: 33628172
Lancet HIV. 2018 Jun;5(6):e277-e290
pubmed: 29703707
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):307-311
pubmed: 32191691
Oman Med J. 2022 May 10;37(3):e370
pubmed: 35602320
Nat Biomed Eng. 2021 Jul;5(7):657-665
pubmed: 34211145
Trop Med Int Health. 2022 May;27(5):522-536
pubmed: 35332616
PLoS One. 2019 Jul 1;14(7):e0218795
pubmed: 31260480
J Diabetes Sci Technol. 2013 Mar 01;7(2):478-88
pubmed: 23567007
BMJ Open. 2021 Sep 2;11(9):e053850
pubmed: 34475190
Front Health Serv Manage. 2020 Fall;37(1):33-38
pubmed: 32842087
Lancet Infect Dis. 2021 Jul;21(7):e183-e190
pubmed: 33357517
PLoS One. 2014 Jul 30;9(7):e103790
pubmed: 25076208
Int J Infect Dis. 2022 Mar;116:358-364
pubmed: 35038598
Popul Health Manag. 2021 Feb;24(S1):S26-S34
pubmed: 33544647
N Engl J Med. 2020 Nov 19;383(21):2030-2040
pubmed: 33031652
JAMA Netw Open. 2021 Jan 4;4(1):e2034001
pubmed: 33471114
J Clin Virol. 2021 Oct;143:104961
pubmed: 34461560
Diagnostics (Basel). 2021 Sep 27;11(10):
pubmed: 34679475
J Multidiscip Healthc. 2022 Jan 11;15:81-92
pubmed: 35046663
CMAJ. 2020 Mar 9;192(10):E264-E265
pubmed: 32152059
Res Nurs Health. 2007 Aug;30(4):459-67
pubmed: 17654487
Front Public Health. 2020 Dec 14;8:585832
pubmed: 33381485
Pan Afr Med J. 2021 Dec 15;40:225
pubmed: 35145587
Open Forum Infect Dis. 2021 Oct 04;8(11):ofab496
pubmed: 34796246
J Hosp Infect. 2021 Feb;108:168-173
pubmed: 33259883
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211047782
pubmed: 34583571
Lancet. 2020 Oct 24;396(10259):1345-1352
pubmed: 33031764
Int J Clin Pract Suppl. 2010 Feb;(166):1-10
pubmed: 20377657
Front Pharmacol. 2020 Sep 11;11:1205
pubmed: 33071775
Cureus. 2017 Aug 21;9(8):e1586
pubmed: 29062618
Clin Infect Dis. 2021 May 4;72(9):e384-e393
pubmed: 32785665
Front Public Health. 2021 Jul 19;9:705031
pubmed: 34350153
EClinicalMedicine. 2021 Oct;40:101113
pubmed: 34490416